<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>05275cam a2200733Ii 4500</leader>
  <controlfield tag="001">ocn826637765</controlfield>
  <controlfield tag="003">OCoLC</controlfield>
  <controlfield tag="005">20171112083120.0</controlfield>
  <controlfield tag="006">m     o  d        </controlfield>
  <controlfield tag="007">cr cnu|||unuuu</controlfield>
  <controlfield tag="008">130204t20132013gw ac   ob    001 0 eng d</controlfield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9783527651085</subfield>
    <subfield code="q">(electronic bk.)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">352765108X</subfield>
    <subfield code="q">(electronic bk.)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9783527651115</subfield>
    <subfield code="q">(electronic bk.)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">352765111X</subfield>
    <subfield code="q">(electronic bk.)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9781299241206</subfield>
    <subfield code="q">(MyiLibrary)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">1299241204</subfield>
    <subfield code="q">(MyiLibrary)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="z">9783527330737</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="z">3527330739</subfield>
  </datafield>
  <datafield tag="029" ind1="1" ind2=" ">
    <subfield code="a">AU@</subfield>
    <subfield code="b">000050562533</subfield>
  </datafield>
  <datafield tag="029" ind1="1" ind2=" ">
    <subfield code="a">AU@</subfield>
    <subfield code="b">000053030546</subfield>
  </datafield>
  <datafield tag="029" ind1="1" ind2=" ">
    <subfield code="a">DKDLA</subfield>
    <subfield code="b">820120-katalog:000655918</subfield>
  </datafield>
  <datafield tag="029" ind1="1" ind2=" ">
    <subfield code="a">NLGGC</subfield>
    <subfield code="b">382514440</subfield>
  </datafield>
  <datafield tag="029" ind1="1" ind2=" ">
    <subfield code="a">NZ1</subfield>
    <subfield code="b">15340091</subfield>
  </datafield>
  <datafield tag="029" ind1="1" ind2=" ">
    <subfield code="a">DEBBG</subfield>
    <subfield code="b">BV043395341</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
    <subfield code="a">(OCoLC)826637765</subfield>
    <subfield code="z">(OCoLC)828869678</subfield>
    <subfield code="z">(OCoLC)828896125</subfield>
    <subfield code="z">(OCoLC)961601655</subfield>
    <subfield code="z">(OCoLC)962705463</subfield>
  </datafield>
  <datafield tag="037" ind1=" " ind2=" ">
    <subfield code="a">455370</subfield>
    <subfield code="b">MIL</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">DG1</subfield>
    <subfield code="b">eng</subfield>
    <subfield code="e">rda</subfield>
    <subfield code="e">pn</subfield>
    <subfield code="c">DG1</subfield>
    <subfield code="d">EBLCP</subfield>
    <subfield code="d">N$T</subfield>
    <subfield code="d">MHW</subfield>
    <subfield code="d">YDXCP</subfield>
    <subfield code="d">COO</subfield>
    <subfield code="d">IDEBK</subfield>
    <subfield code="d">E7B</subfield>
    <subfield code="d">NOC</subfield>
    <subfield code="d">OCLCF</subfield>
    <subfield code="d">IUL</subfield>
    <subfield code="d">SCB</subfield>
    <subfield code="d">OCLCQ</subfield>
    <subfield code="d">CDX</subfield>
    <subfield code="d">NKT</subfield>
    <subfield code="d">OCLCQ</subfield>
  </datafield>
  <datafield tag="049" ind1=" " ind2=" ">
    <subfield code="a">MAIN</subfield>
  </datafield>
  <datafield tag="050" ind1=" " ind2="4">
    <subfield code="a">RM301.25</subfield>
    <subfield code="b">.A53 2013</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">MED</subfield>
    <subfield code="x">023000</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">MED</subfield>
    <subfield code="x">058170</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">MED</subfield>
    <subfield code="x">071000</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">MED</subfield>
    <subfield code="x">072000</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">HEA</subfield>
    <subfield code="2">eflch</subfield>
  </datafield>
  <datafield tag="082" ind1="0" ind2="4">
    <subfield code="a">615.1/9</subfield>
    <subfield code="2">23</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
    <subfield code="a">Analogue-based drug discovery III /</subfield>
    <subfield code="c">edited by J&#xE1;nos Fischer, C. Robin Ganellin, David P. Rotella.</subfield>
    <subfield code="h">[electronic resource]</subfield>
  </datafield>
  <datafield tag="246" ind1="3" ind2=" ">
    <subfield code="a">Analogue-based drug discovery 3</subfield>
  </datafield>
  <datafield tag="246" ind1="3" ind2=" ">
    <subfield code="a">Analog-based drug discovery III</subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2="1">
    <subfield code="a">Weinheim :</subfield>
    <subfield code="b">Wiley-VCH,</subfield>
    <subfield code="c">[2013]</subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2="4">
    <subfield code="c">&#xA9;2013</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">1 online resource (xviii, 385 pages) :</subfield>
    <subfield code="b">illustrations, portraits</subfield>
  </datafield>
  <datafield tag="336" ind1=" " ind2=" ">
    <subfield code="a">text</subfield>
    <subfield code="b">txt</subfield>
    <subfield code="2">rdacontent</subfield>
  </datafield>
  <datafield tag="337" ind1=" " ind2=" ">
    <subfield code="a">computer</subfield>
    <subfield code="b">c</subfield>
    <subfield code="2">rdamedia</subfield>
  </datafield>
  <datafield tag="338" ind1=" " ind2=" ">
    <subfield code="a">online resource</subfield>
    <subfield code="b">cr</subfield>
    <subfield code="2">rdacarrier</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
    <subfield code="a">Includes bibliographical references and index.</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2="0">
    <subfield code="t">General Aspects. Pioneer and Analogue Drugs /</subfield>
    <subfield code="r">Janos Fischer, C Robin Ganellin, David P Rotella --</subfield>
    <subfield code="t">Competition in the Pharmaceutical Drug Development /</subfield>
    <subfield code="r">Christian Tyrchan, Fabrizio Giordanetto --</subfield>
    <subfield code="t">Metabolic Stability and Analogue-Based Drug Discovery /</subfield>
    <subfield code="r">Amit S Kalgutkar, Antonia F Stepan --</subfield>
    <subfield code="t">Use of Macrocycles in Drug Design Exemplified with Ulimorelin, a Potential Ghrelin Agonist for Gastrointestinal Motility Disorders /</subfield>
    <subfield code="r">Mark L Peterson, Hamid Hoveyda, Graeme Fraser, Eric Marsault, Rene Gagnon --</subfield>
    <subfield code="t">Drug Classes. The Discovery of Anticancer Drugs Targeting Epigenetic Enzymes /</subfield>
    <subfield code="r">A Ganesan --</subfield>
    <subfield code="t">Thienopyridyl and Direct-Acting P2Y Receptor Antagonist Antiplatelet Drugs /</subfield>
    <subfield code="r">Joseph A Jakubowski, Atsuhiro Sugidachi --</subfield>
    <subfield code="t">Selective Estrogen Receptor Modulators /</subfield>
    <subfield code="r">Amarjit Luniwal, Rachael Jetson, Paul Erhardt --</subfield>
    <subfield code="t">Discovery of Nonpeptide Vasopressin V2 Receptor Antagonists /</subfield>
    <subfield code="r">Kazumi Kondo, Hidenori Ogawa --</subfield>
    <subfield code="t">The Development of Cysteinyl Leukotriene Receptor Antagonists /</subfield>
    <subfield code="r">Peter R Bernstein --</subfield>
    <subfield code="t">Case Studies. The Discovery of Dabigatran Etexilate /</subfield>
    <subfield code="r">Norbert Hauel, Andreas Clemens, Herbert Nar, Henning Priepke, Joanne van Ryn, Wolfgang Wienen --</subfield>
    <subfield code="t">The Discovery of Citalopram and Its Refinement to Escitalopram /</subfield>
    <subfield code="r">Klaus P Bogeso, Connie Sanchez --</subfield>
    <subfield code="t">Tapentadol : From Morphine and Tramadol to the Discovery of Tapentadol /</subfield>
    <subfield code="r">Helmut Buschmann --</subfield>
    <subfield code="t">Novel Taxanes: Cabazitaxel Case Study /</subfield>
    <subfield code="r">Herve Bouchard, Dorothee Semiond, Marie-Laure Risse, Patricia Vrignaud --</subfield>
    <subfield code="t">Discovery of Boceprevir and Narlaprevir: A Case Study for Role of Structure-Based Drug Design /</subfield>
    <subfield code="r">Srikanth Venkatraman, Andrew Prongay, George F Njoroge --</subfield>
    <subfield code="t">A New-Generation Uric Acid Production Inhibitor: Febuxostat /</subfield>
    <subfield code="r">Ken Okamoto, Shiro Kondo, Takeshi Nishino.</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">"Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and--together with the previous volumes--constitutes the first systematic approach to drug analogue development"--Publisher's website.</subfield>
  </datafield>
  <datafield tag="588" ind1="0" ind2=" ">
    <subfield code="a">Online resource; title page from PDF title page (viewed June 30, 2014).</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Drug development.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">MEDICAL</subfield>
    <subfield code="x">Drug Guides.</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">MEDICAL</subfield>
    <subfield code="x">Nursing</subfield>
    <subfield code="x">Pharmacology.</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">MEDICAL</subfield>
    <subfield code="x">Pharmacology.</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">MEDICAL</subfield>
    <subfield code="x">Pharmacy.</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="7">
    <subfield code="a">Drug development.</subfield>
    <subfield code="2">fast</subfield>
    <subfield code="0">(OCoLC)fst00898670</subfield>
  </datafield>
  <datafield tag="655" ind1=" " ind2="4">
    <subfield code="a">Electronic books.</subfield>
  </datafield>
  <datafield tag="655" ind1=" " ind2="7">
    <subfield code="a">Electronic books.</subfield>
    <subfield code="2">local</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Fischer, J&#xE1;nos,</subfield>
    <subfield code="e">editor.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Ganellin, C. R.</subfield>
    <subfield code="q">(C. Robin),</subfield>
    <subfield code="e">editor.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Rotella, David P.,</subfield>
    <subfield code="e">editor.</subfield>
  </datafield>
  <datafield tag="776" ind1="0" ind2="8">
    <subfield code="i">Print version:</subfield>
    <subfield code="t">Analogue-based drug discovery III.</subfield>
    <subfield code="d">Weinheim : Wiley-VCH, [2013]</subfield>
    <subfield code="z">9783527330737</subfield>
    <subfield code="w">(OCoLC)825555931</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
    <subfield code="u">http://onlinelibrary.wiley.com/book/10.1002/9783527651085</subfield>
    <subfield code="z">Wiley Online Library</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="c">BK</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">206390</subfield>
    <subfield code="d">206390</subfield>
  </datafield>
</record>
